Synovitis and its association with elevated circulating interferons and hydroxychloroquine response in discoid lupus erythematosus: a cross-sectional study
Rheumatology International · 2025
DOI: 10.1007/s00296-025-05816-4 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Rheumatology International, 2025. Verfasst von Magdalena Stec und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Dermatology in Zabrze, Medical University of Silesia, Maria Curie-Sklodowska Street 10, Zabrze, 41-800, Poland. Hauptthemen laut MEDLINE: Hydroxychloroquine, Synovitis, Lupus Erythematosus, Discoid, Antirheumatic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
A significant proportion of patients with discoid lupus erythematosus (DLE) experience joint pain, yet its underlying pathomechanism remains unclear. Recent ultrasound studies in systemic lupus erythematosus (SLE) patients indicate synovitis in up to 90%, even in clinically silent cases, with interferon-mediated immune responses implicated in joint inflammation. This study aimed to investigate joint pathology in DLE, focusing on synovitis and its immunological profile. We analyzed 23 patients with histologically confirmed DLE and joint pain, all treated for ≥ 5 months with prednisone (≤ 10 mg/day) and hydroxychloroquine (HCQ, 200 mg/day). Ultrasonographic assessment (24 joints per patient) was performed using power Doppler (PD) ultrasonography, with synovitis graded using the OMERACT-EULAR PDUS synovitis score. Serum levels of 37 cytokines were measured via Bio-Plex Pro™ Human Inflammation Panel (37Plex). Synovitis (OMERACT-EULAR score ≥ 1) was identified in 30% (7/23) of DLE patients, with minimal (grade 1) synovitis in six cases and moderate (grade 2) synovitis in one. Patients with synovitis had significantly higher levels of IFN-α2, IFN-γ, MMP-1, MMP-3, sTNF-R1, and sTNF-R2 (p < 0.05), more painful joints, and poorer response to HCQ treatment (71.4% vs. 25% non-responders). Joint pain in DLE may result from synovitis, with an interferon-mediated immune response contributing to inflammation. Patients with synovitis exhibited elevated interferon levels and a worse response to HCQ therapy. These findings suggest a shared pathogenic mechanism between DLE and SLE-related arthritis, warranting further investigation into targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Department of Dermatology in Zabrze, Medical University of Silesia, Maria Curie-Sklodowska Street 10, Zabrze, 41-800, Poland.
- Clinical Department of Rheumatology and Immunology, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
- John Paul II Hospital, Krakow, Poland.
- Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
- Clinical Department of Dermatology in Zabrze, Medical University of Silesia, Maria Curie-Sklodowska Street 10, Zabrze, 41-800, Poland. pastuszczak.maciej@gmail.com.
ORCID-Profile: Ewa Wypasek, Bogdan Batko, Maciej Pastuszczak
Zitieren
APA
Stec, M., Krezelok, M., Awsiuk, M., Wypasek, E., Batko, B., & Pastuszczak, M. (2025). Synovitis and its association with elevated circulating interferons and hydroxychloroquine response in discoid lupus erythematosus: a cross-sectional study. Rheumatology International. https://doi.org/10.1007/s00296-025-05816-4
Vancouver
Stec M, Krezelok M, Awsiuk M, Wypasek E, Batko B, Pastuszczak M. Synovitis and its association with elevated circulating interferons and hydroxychloroquine response in discoid lupus erythematosus: a cross-sectional study. Rheumatology International. 2025. doi:10.1007/s00296-025-05816-4
BibTeX
@article{Stec2025,
author = {Stec, Magdalena and Krezelok, Monika and Awsiuk, Magdalena and Wypasek, Ewa and Batko, Bogdan and Pastuszczak, Maciej},
title = {Synovitis and its association with elevated circulating interferons and hydroxychloroquine response in discoid lupus erythematosus: a cross-sectional study},
journal = {Rheumatology International},
year = {2025},
doi = {10.1007/s00296-025-05816-4}
}
EUVIMED